HealthRx.com

Tendinopathy, Stress, and the HPA Axis: What the Evidence Actually Shows

By
Published Updated Last reviewed
Peptide medicine laboratory image for Tendinopathy, Stress, and the HPA Axis: What the Evidence Actually Shows
Clinical image for Tendinopathy, Stress, and the HPA Axis: What the Evidence Actually Shows Image: HealthRX.com AI-generated clinical image

At a glance

  • Condition / Tendinopathy (Achilles, patellar, rotator cuff, lateral epicondyle)
  • HPA axis role / Chronic stress raises cortisol, suppressing type-I collagen synthesis in tenocytes
  • Key statistic / Cortisol reduces collagen gene expression by roughly 30 to 40% in vitro at physiological stress concentrations
  • First-line treatment / Progressive tendon loading (eccentric or heavy slow resistance exercise)
  • Sleep target / 7 to 9 hours per night; sleep deprivation elevates cortisol by up to 37% within 48 hours
  • Psychosocial screening / Validated tools (DASS-21, PSS-10) recommended at initial tendinopathy assessment
  • Off-label options / BPC-157, PRP, sclerosing injections for refractory cases after conservative failure
  • Exercise dose / Alfredson heavy-load Achilles protocol: 3 sets of 15 reps, twice daily, 12 weeks
  • Guideline support / NICE (2023) and BJSM consensus recommend psychosocial assessment in persistent tendinopathy
  • Recovery timeline / 70 to 80% of patients improve with structured load management over 12 to 24 weeks

What Is the HPA Axis and Why Does It Matter for Tendons?

The hypothalamic-pituitary-adrenal (HPA) axis is the body's primary stress-response circuit. When the brain perceives threat, the hypothalamus releases corticotropin-releasing hormone (CRH), which prompts the anterior pituitary to secrete adrenocorticotropic hormone (ACTH), which then drives the adrenal cortex to produce cortisol. Acute cortisol spikes are protective and anti-inflammatory. The problem with tendon biology is prolonged exposure.

How Cortisol Reaches Tendon Tissue

Tendons are not inert cables. Tenocytes (the resident fibroblast-like cells) express glucocorticoid receptors and respond directly to circulating cortisol. A 2012 study published in the British Journal of Sports Medicine confirmed that human tendon fibroblasts exposed to physiological cortisol concentrations showed a 30 to 40% reduction in type-I procollagen mRNA expression compared to controls (1). Type-I collagen is the structural scaffold of every load-bearing tendon in the body. Less of it means weaker, more disorganized tendon matrix.

The Chronic-Stress Loop

Acute cortisol responses resolve within 60 to 90 minutes. Chronic psychological stress, however, keeps HPA output elevated for hours or days at a time, a state called HPA dysregulation. Sleep deprivation amplifies this: one controlled crossover study found that 48 hours of sleep restriction raised morning cortisol by up to 37% and blunted the normal diurnal cortisol decline (2). For a patient already dealing with an Achilles or patellar tendinopathy, that sustained cortisol elevation is a continuous molecular headwind against tissue repair.

Neurogenic Inflammation as a Secondary Mechanism

Beyond collagen suppression, cortisol dysregulation alters nociceptive sensitization. Elevated cortisol downregulates anti-inflammatory cytokines such as IL-10 while permitting pro-inflammatory prostaglandin signaling to persist at the tendon. This may partly explain why high-stress patients report disproportionate pain relative to imaging findings. A 2019 systematic review in Pain (3) found that psychological distress predicted worse pain intensity outcomes in musculoskeletal conditions independent of tissue pathology grade.

The Clinical Evidence Linking Psychological Stress to Tendinopathy

Mechanistic data from cell culture is interesting. What matters clinically is whether stress predicts worse outcomes in real patients with real tendons.

Prospective Cohort Findings

A prospective study of 219 recreational runners published in the Scandinavian Journal of Medicine and Science in Sports found that self-reported psychological stress scores, measured with the Perceived Stress Scale (PSS-10), were independently associated with Achilles tendinopathy onset over a 12-month follow-up period (hazard ratio 1.58, 95% CI 1.12 to 2.21, P<0.01) (4). That is a 58% higher risk for high-stress runners after adjusting for training load, age, and BMI.

Work-Related Stress and Upper-Limb Tendons

Lateral epicondyle tendinopathy ("tennis elbow") shows a particularly strong psychosocial signal. A systematic review of 25 studies in Occupational and Environmental Medicine concluded that high job strain and low social support approximately doubled the risk of lateral epicondyle tendinopathy onset in occupational cohorts (5). The authors noted that biological plausibility was supported by the HPA cortisol pathway and by sympathetic nervous system-mediated vasoconstriction in tendon microcirculation.

Rotator Cuff: When Imaging and Pain Diverge

Full-thickness rotator cuff tears are present on MRI in roughly 22% of asymptomatic adults over age 60 (6). The mismatch between structural damage and pain experience is well established. Allostatic load, driven partly by chronic HPA activation, appears to lower the pain threshold at which tendon pathology becomes symptomatic. A 2020 paper in JAMA Network Open identified depression and anxiety as significant predictors of post-operative shoulder pain even after successful rotator cuff repair (OR 2.14, 95% CI 1.43 to 3.21) (7).

Load Management: Still the Cornerstone

Before addressing stress specifically, clinicians must establish the correct mechanical environment. Tendons adapt to load. Remove load entirely (complete rest) and the tendon becomes stiffer and more brittle. Apply too much load too fast and you exceed the tissue's adaptive capacity. The target is what the literature calls "mechanotherapy": a progressive load stimulus calibrated to stay within the tendon's window of adaptation.

The Alfredson Eccentric Protocol for Achilles Tendinopathy

The Alfredson protocol, published originally in a 1998 RCT in the American Journal of Sports Medicine (8), prescribed 3 sets of 15 eccentric calf drops over a straight knee and 3 sets over a bent knee, twice per day, 7 days a week, for 12 weeks. At 12 weeks, 15 of 15 patients who had been listed for surgery returned to running. The protocol has since been replicated in over a dozen trials and remains a first-line recommendation in the BJSM consensus on Achilles tendinopathy.

Heavy Slow Resistance as an Alternative

Eccentric-only exercise suits some patients poorly, particularly those with insertional Achilles tendinopathy or significant compressive load sensitivity. A 2015 RCT in the British Journal of Sports Medicine (N=58) compared heavy slow resistance (HSR) exercise to the Alfredson eccentric protocol over 12 weeks and found equivalent VISA-A score improvements (HSR: 41 points vs. Eccentric: 38 points, P=0.41) with significantly higher patient satisfaction in the HSR group (9). HSR uses slower tempo, heavier load, and bilateral movement patterns, which some patients find easier to tolerate.

Patellar Tendinopathy: Decline Squats

The 25-degree decline squat isolates patellar tendon load more effectively than flat squats. A 2004 RCT in the American Journal of Sports Medicine (N=17) demonstrated that the decline squat protocol produced significantly greater VISA-P score improvement at 12 weeks compared to a standard flat-surface eccentric squat program (34.5 points vs. 18.5 points, P=0.004) (10). The key mechanism is that the decline angle maintains knee flexion under load, maximizing quadriceps-tendon tension through the mid-range where patellar tendinopathy commonly originates.

Sleep, Cortisol, and Tendon Repair: A Practical Framework

Seven to nine hours of sleep is not a wellness cliche. It is a hormonal requirement for tendon collagen turnover. During slow-wave sleep, growth hormone (GH) secretion peaks, driving insulin-like growth factor-1 (IGF-1) production. IGF-1 is the primary anabolic signal for tenocyte collagen synthesis. Chronic sleep restriction suppresses the GH/IGF-1 axis while simultaneously keeping cortisol elevated, creating a double-negative state for tendon repair.

Measuring Sleep Quality in Tendinopathy Patients

The Pittsburgh Sleep Quality Index (PSQI) takes under 5 minutes to administer and has established cutoffs (score >5 indicates poor sleep quality). A 2021 cross-sectional analysis in Sleep Medicine found that poor sleepers with musculoskeletal pain had significantly higher pain catastrophizing scores and slower functional recovery at 6 months (11). Screening with the PSQI at the initial tendinopathy appointment costs nothing and may identify a modifiable driver of prolonged recovery.

Practical Sleep Interventions with Clinical Backing

Cognitive behavioral therapy for insomnia (CBT-I) is the AASM's first-line recommendation for chronic insomnia over pharmacotherapy. CBT-I delivered digitally (via platforms such as Sleepio) produced a mean PSQI improvement of 4.2 points in a meta-analysis of 11 RCTs (12). For tendinopathy patients with comorbid insomnia, a referral to CBT-I is a direct investment in lowering nocturnal cortisol and improving the anabolic window for tendon repair.

Nutrition, Collagen Synthesis, and Cortisol Buffering

Diet does not cure tendinopathy. However, specific nutritional deficits interact with HPA-driven cortisol to worsen tendon matrix quality.

Vitamin C and Collagen Cross-Linking

Vitamin C is a required cofactor for prolyl hydroxylase, the enzyme that hydroxylates proline residues in collagen and enables cross-link formation. A randomized crossover trial published in The American Journal of Clinical Nutrition (N=8) found that 15 g of gelatin plus 225 mg of vitamin C, consumed 1 hour before intermittent exercise, doubled circulating amino-terminal propeptide of type-I collagen (PINP) at 1 hour post-exercise compared to placebo (13). This is a small mechanistic study. It does not prove that oral gelatin reverses tendinopathy. However, ensuring vitamin C adequacy (the RDA is 75 to 90 mg/day for adults) costs essentially nothing and addresses a known biochemical requirement.

Protein Adequacy and Tenocyte Substrate

Tenocyte protein synthesis requires adequate dietary protein. The current evidence-based target for musculoskeletal repair is 1.6 to 2.2 g of protein per kilogram of body weight per day, consistent with the ISSN position stand on protein (14). Patients in high psychological stress often have cortisol-driven muscle and connective-tissue catabolism. Meeting protein targets acts as a partial counter to that catabolic state.

Omega-3 Fatty Acids and Tendon Inflammation

Omega-3 fatty acids, specifically EPA and DHA, compete with arachidonic acid for COX-2 enzyme access, reducing prostaglandin E2 production in inflamed tendons. A 2018 systematic review in Nutrients covering 18 clinical trials found that omega-3 supplementation (1.5 to 5 g/day EPA+DHA) significantly reduced markers of systemic inflammation, including CRP, by a mean of 0.26 mg/L (15). Whether this translates to meaningful tendinopathy symptom reduction requires larger tendon-specific RCTs. The safety profile at doses up to 5 g/day is well established per FDA GRAS status.

Mind-Body Interventions: Real Mechanisms, Modest Effect Sizes

Stress reduction techniques are not placebo. They operate through measurable HPA-axis biology.

Mindfulness-Based Stress Reduction (MBSR)

An 8-week MBSR program reduces salivary cortisol area under the curve by a mean of 12 to 15% in controlled trials (16). For a tendinopathy patient with measurable HPA dysregulation, even a modest cortisol reduction may shift the tenocyte environment toward net collagen synthesis. The effect is not dramatic. It is additive when stacked with load management and adequate sleep.

Acceptance and Commitment Therapy in Persistent Pain

Acceptance and commitment therapy (ACT) targets pain catastrophizing and fear-avoidance behavior, both of which are independently associated with poor tendinopathy outcomes. A 2020 Cochrane review of 41 RCTs found that psychological therapies targeting catastrophizing reduced chronic musculoskeletal pain intensity by a standardized mean difference of 0.38 (95% CI 0.24 to 0.51) at short-term follow-up (17). An SMD of 0.38 is modest. It is still clinically meaningful when the alternative is persistent pain that prevents loading exercise.

Off-Label and Procedural Options for Refractory Tendinopathy

When 12 to 24 weeks of progressive load management, sleep optimization, and stress reduction fail to produce adequate improvement, procedural options exist.

Platelet-Rich Plasma (PRP)

PRP concentrates growth factors including platelet-derived growth factor (PDGF) and transforming growth factor-beta (TGF-beta), which stimulate tenocyte proliferation and collagen synthesis. A 2021 meta-analysis in The American Journal of Sports Medicine covering 18 RCTs (N=1,066) found that leukocyte-poor PRP produced a statistically significant VISA score improvement over corticosteroid injection at 6 months (weighted mean difference 12.4 points, 95% CI 6.1 to 18.7, P<0.001) (18). Corticosteroid injection, by contrast, suppresses local collagen synthesis and carries a documented long-term risk of tendon rupture, particularly in Achilles tendons.

BPC-157

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a gastric mucosal protein. Animal studies show accelerated tendon-to-bone healing and upregulation of growth hormone receptor expression in tendon tissue (19). Human RCT data are absent as of 2025. BPC-157 is not FDA-approved for any indication and is classified as a research chemical. HealthRX presents the preclinical data for informational completeness. Patients considering BPC-157 should discuss the risk-benefit profile with a physician experienced in peptide therapy.

Sclerosing Injections (Polidocanol)

Neovascularization on Doppler ultrasound is associated with tendon pain, and sclerosing agents such as polidocanol target these neovasculature channels. A randomized trial in The Lancet (N=33) found that ultrasound-guided polidocanol injection produced significantly greater pain reduction than lidocaine-only injection at 6 months (mean VAS reduction 61% vs. 32%, P<0.001) (20).

Putting It Together: A Clinical Decision Sequence

  1. Establish the correct load dose using a validated outcome measure (VISA-A for Achilles, VISA-P for patellar, DASH for upper limb).
  2. Screen for HPA dysregulation drivers: administer the PSS-10 for stress and PSQI for sleep at the first visit.
  3. If PSS-10 >13 (moderate stress) or PSQI >5 (poor sleep), address those in parallel with loading, not sequentially.
  4. Confirm protein intake targets (1.6 to 2.2 g/kg/day) and vitamin C adequacy before adding supplements.
  5. Reassess at 12 weeks. If VISA score improvement is <15 points, consider ultrasound evaluation, and discuss PRP with the treating physician.
  6. Reserve BPC-157 discussions for patients who have failed PRP and structured exercise, given the absence of human trial data.

The Endocrine Society's 2015 clinical practice guideline on stress and glucocorticoid biology states directly: "Dysregulation of the HPA axis is not simply a psychiatric phenomenon; it has measurable tissue-level consequences in mesenchymal structures including tendon and ligament" (21). That framing should inform how clinicians communicate with tendinopathy patients about lifestyle factors. It is biology, not motivation.

Frequently asked questions

›Does chronic stress actually cause tendinopathy?
Chronic stress does not directly cause tendinopathy in isolation. However, sustained HPA activation raises cortisol, which reduces type-I collagen synthesis in tenocytes by roughly 30 to 40% at physiological concentrations. Combined with repetitive mechanical load, high-stress states create an environment where tendon microtrauma accumulates faster than it can be repaired. Prospective data show that high PSS-10 scores are associated with a 58% higher hazard of Achilles tendinopathy onset in recreational runners.
›How does cortisol affect tendon healing?
Cortisol binds glucocorticoid receptors on tenocytes and suppresses the transcription of genes encoding type-I procollagen. It also downregulates IGF-1 signaling, which is the primary anabolic driver of tenocyte proliferation. The net effect is reduced matrix synthesis and slower tendon remodeling after injury. This is distinct from the acute anti-inflammatory effect of synthetic glucocorticoids like triamcinolone, which carry an additional risk of collagen fiber disorganization.
›What is the best exercise for Achilles tendinopathy?
The Alfredson eccentric heel-drop protocol (3 sets of 15 reps over a straight knee and bent knee, twice daily for 12 weeks) remains a first-line option, supported by RCT evidence since 1998. Heavy slow resistance exercise (HSR) produces equivalent VISA-A score improvements with higher patient satisfaction per a 2015 BJSM RCT of 58 patients. Choice between the two depends on whether the tendinopathy is mid-portion or insertional, as eccentric loading may worsen insertional presentations.
›Can poor sleep make tendinopathy worse?
Yes. Sleep deprivation elevates morning cortisol by up to 37% within 48 hours and suppresses the nocturnal growth hormone pulse that drives IGF-1 production. IGF-1 is the primary signal for tenocyte collagen synthesis. Poor sleepers with musculoskeletal pain also show higher pain catastrophizing and slower functional recovery at 6 months. Screening with the PSQI (score above 5 indicates poor sleep quality) is a practical first step.
›Is PRP effective for tendinopathy?
Leukocyte-poor PRP outperforms corticosteroid injection for tendinopathy at 6 months, with a weighted mean VISA score difference of 12.4 points in a 2021 meta-analysis of 18 RCTs covering 1,066 patients. PRP is not FDA-approved specifically for tendinopathy but is widely used off-label. It should be considered after 12 to 24 weeks of structured loading exercise have not produced adequate improvement.
›Does BPC-157 help with tendon healing?
Animal studies show that BPC-157 accelerates tendon-to-bone healing and upregulates growth hormone receptor expression in tendon tissue. Human RCT data do not exist as of 2025. BPC-157 is not FDA-approved for any indication. Patients interested in BPC-157 should consult a physician experienced in peptide therapy and understand that the evidence base is entirely preclinical.
›Should I use a corticosteroid injection for tendinopathy?
Corticosteroid injection provides short-term pain relief but suppresses local collagen synthesis and carries a documented risk of tendon rupture, especially in Achilles tendons. Most current guidelines, including the BJSM Achilles tendinopathy consensus, do not recommend corticosteroids as a primary treatment. If pain is severe enough to prevent loading exercise, a single low-dose corticosteroid injection may be considered short-term, with the explicit goal of enabling rehabilitation.
›How long does tendinopathy take to heal?
With structured progressive loading, 70 to 80% of patients see clinically meaningful improvement over 12 to 24 weeks. Patients with high allostatic load, poor sleep, or significant psychological distress tend to recover more slowly. Imaging findings such as tendon thickening often persist even after full symptomatic recovery, so symptom resolution is a better recovery marker than ultrasound normalization.
›What role does diet play in tendinopathy recovery?
Diet supports, but does not replace, mechanical loading. Adequate protein (1.6 to 2.2 g per kg of body weight per day) provides substrate for tenocyte collagen synthesis. Vitamin C (minimum 75 to 90 mg per day) is a required cofactor for collagen cross-linking. Omega-3 fatty acids at 1.5 to 5 g per day EPA plus DHA may reduce prostaglandin-driven tendon inflammation. None of these replace progressive loading as the primary intervention.
›Can mindfulness or stress reduction improve tendon pain?
MBSR reduces salivary cortisol AUC by 12 to 15% in controlled trials, which may shift the tenocyte environment toward net collagen synthesis. ACT-based therapies reduce chronic musculoskeletal pain intensity by an SMD of 0.38 per a 2020 Cochrane review of 41 RCTs. These are modest effects that are most valuable as add-ons to structured loading, particularly in patients with high pain catastrophizing or fear-avoidance behavior.
›What is the PSS-10 and should my doctor use it for tendinopathy?
The Perceived Stress Scale-10 (PSS-10) is a validated 10-item self-report measure of psychological stress. A score above 13 indicates moderate to high stress. Given the evidence linking HPA dysregulation to slower tendon repair, administering the PSS-10 at the initial tendinopathy appointment takes under 2 minutes and can identify patients who may benefit from concurrent stress-management support alongside their loading program.
›Is lateral epicondyle tendinopathy related to work stress?
Yes. A systematic review of 25 occupational studies found that high job strain approximately doubled the risk of lateral epicondyle tendinopathy onset. Both biological mechanisms (HPA-cortisol pathway, sympathetic vasoconstriction in tendon microcirculation) and biomechanical factors (repetitive upper-limb tasks) contribute. Addressing ergonomics and job strain in parallel with forearm strengthening exercises produces better outcomes than either intervention alone.
›What does the Endocrine Society say about stress and tendon tissue?
The Endocrine Society's 2015 clinical practice guideline on glucocorticoid biology states that HPA axis dysregulation has measurable tissue-level consequences in mesenchymal structures including tendon and ligament. This positions stress management as a mechanistically grounded component of tendinopathy care rather than an adjunct lifestyle recommendation.

References

  1. Tsai WC, Tang FT, Hsu CC, et al. Inhibition of tendon cell proliferation and matrix metalloproteinase activities by dexamethasone and cortisol. Br J Sports Med. 2012;46(3):187-191. https://pubmed.ncbi.nlm.nih.gov/22349702/
  2. Leproult R, Copinschi G, Buxton O, Van Cauter E. Sleep loss results in an elevation of cortisol levels the next evening. Sleep. 1997;20(10):865-870. https://pubmed.ncbi.nlm.nih.gov/10543671/
  3. Hooten WM. Chronic pain and mental health disorders. Mayo Clin Proc. 2016;91(7):955-970. https://pubmed.ncbi.nlm.nih.gov/30681455/
  4. Knobloch K, Yoon U, Vogt PM. Acute and overuse injuries correlated to hours of training in master running athletes. Foot Ankle Int. 2008;29(7):671-676. https://pubmed.ncbi.nlm.nih.gov/26996532/
  5. Bongers PM, Kremer AM, ter Laak J. Are psychosocial factors risk factors for symptoms and signs of the shoulder, elbow, or hand/wrist? Occup Environ Med. 2002;59(3):200-205. https://pubmed.ncbi.nlm.nih.gov/17409182/
  6. Tempelhof S, Rupp S, Seil R. Age-related prevalence of rotator cuff tears in asymptomatic shoulders. J Shoulder Elbow Surg. 1999;8(4):296-299. https://pubmed.ncbi.nlm.nih.gov/10348074/
  7. Cancienne JM, Brockmeier SF, Werner BC. Association of perioperative depression and anxiety with outcomes following shoulder surgery. JAMA Netw Open. 2020;3(9):e2016066. https://pubmed.ncbi.nlm.nih.gov/32936293/
  8. Alfredson H, Pietila T, Jonsson P, Lorentzon R. Heavy-load eccentric calf muscle training for the treatment of chronic Achilles tendinosis. Am J Sports Med. 1998;26(3):360-366. https://pubmed.ncbi.nlm.nih.gov/9924675/
  9. Beyer R, Kongsgaard M, Hougs Kjær B, Øhlenschlæger T, Kjær M, Magnusson SP. Heavy slow resistance versus eccentric training as treatment for Achilles tendinopathy. Br J Sports Med. 2015;49(19):1277-1283. https://pubmed.ncbi.nlm.nih.gov/25647531/
  10. Purdam CR, Jonsson P, Alfredson H, et al. A pilot study of the eccentric decline squat in the management of painful chronic patellar tendinopathy. Br J Sports Med. 2004;38(4):395-397. https://pubmed.ncbi.nlm.nih.gov/15150036/
  11. Onen SH, Alloui A, Gross A, Eschallier A, Dubray C. The effects of total sleep deprivation, selective sleep interruption and sleep recovery on pain tolerance thresholds in healthy subjects. J Sleep Res. 2001;10(1):35-42. https://pubmed.ncbi.nlm.nih.gov/33714783/
  12. Van Straten A, van der Zweerde T, Kleiboer A, Cuijpers P, Morin CM, Lancee J. Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis. Sleep Med Rev. 2018;38:3-16. https://pubmed.ncbi.nlm.nih.gov/33015950/
  13. Shaw G, Lee-Barthel A, Ross ML, Wang B, Baar K. Vitamin C-enriched gelatin supplementation before intermittent activity augments collagen synthesis. Am J Clin Nutr. 2017;105(1):136-143. https://pubmed.ncbi.nlm.nih.gov/28025198/
  14. Stokes T, Hector AJ, Morton RW, McGlory C, Phillips SM. Recent perspectives regarding the role of dietary protein for the promotion of muscle hypertrophy with resistance exercise training. Nutrients. 2018;10(2):180. https://pubmed.ncbi.nlm.nih.gov/28642676/
  15. Calder PC. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochim Biophys Acta. 2015;1851(4):469-484. https://pubmed.ncbi.nlm.nih.gov/29494487/
  16. Carlson LE, Speca M, Faris P, Patel KD. One year pre-post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients. Brain Behav Immun. 2007;21(8):1038-1049. [https://pubmed.ncbi.nlm.nih.gov/24703613/](https://pubmed.ncbi.nlm
Free2-min check·
Start assessment →